About IGVF

UI:8.32.1

About the IGVF Consortium

The Impact of Genomic Variation on Function (IGVF) Consortium is an ongoing international collaboration of research groups funded by the National Human Genome Research Institute (NHGRI). The IGVF Consortium aims to understand how genomic variation affects genome function, which in turn impacts phenotype. The NHGRI is funding this collaborative program that brings together teams of investigators who will use state-of-the-art experimental and computational approaches to model, predict, characterize and map genome function, how genome function shapes phenotype, and how these processes are affected by genomic variation. These joint efforts will produce a catalog of the impact of genomic variants on genome function and phenotypes.

More information can be found at igvf.org

About the IGVF DACC

The IGVF Data and Administrative Coordination Center (DACC)'s primary task is to curate, uniformly process and validate the data generated and submitted by IGVF Consortium members in preparation for release to the scientific community. Click through our documentation to learn more about our methods and visit the IGVF DACC Github repo for the code behind the DACC-created IGVF Portal and more!

Contact

For questions about the IGVF Portal or IGVF data, please email igvf-portal-help@lists.stanford.edu. For additional information you can subscribe to the IGVF mailing list: igvf-support@gowustl.onmicrosoft.com or the all consortium mailing list: igvf-allconsortium@gowustl.onmicrosoft.com

Follow us on Twitter: @IGVFConsortium

DACC staff and individual contact information are listed on the Cherry Lab page, the Gerstein Lab page, and the Wang Lab page.

Acknowledgments

Funding

The IGVF DACC is currently funded by a U24 grant from the National Human Genome Research Institute at the U.S. National Institutes of Health (HG012012 and HG012070). The content of this website is solely the responsibility of the contributors and does not necessarily represent the official views of the National Human Genome Research Institute or the National Institutes of Health.